New Fashion Design for Rapid Antigen Diagnostic Test - EZER Flu&Covid-19 Antigen Duo rapid test – Genesis
New Fashion Design for Rapid Antigen Diagnostic Test - EZER Flu&Covid-19 Antigen Duo rapid test – Genesis Detail:
Introduction
Clinical signs and symptoms of respiratory viral infection due to SARS-CoV-2 and influenza can be similar. SARSCoV-2, influenza A and influenza B viral antigens are generally detectable in upper respiratory specimens during the acute phase of infection.
Influenza virus belongs to the family of Orthomyxoviridae, and immunologically diverse, single-stranded RNA viruses. There influenza A and B virus is the main pathogen that severe illnesses both in human and in many animal species. Based on the current epidemiological investigation, the incubation period is 1 to 4 days. The main manifestations include acute fever, general aching and respiratory symptoms. Both Type A and B viruses can circulate simultaneously, but usually one type is dominant during a given season.1
COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main manifestations include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.
EZERTM Flu & COVID-19 Antigen Duo Rapid Test is intended for the simultaneous qualitative detection and differentiation of the nucleocapsid protein antigens from SARS-CoV-2, influenza A and influenza B in direct nasopharyngeal (NP) specimens. The detection is based on the antibodies which were developed specifically recognizing and reacting with the nucleoprotein of virus.
Detection
EZERTM Flu & COVID-19 Antigen Duo Rapid Test is the simultaneous qualitative detection and differentiation of the nucleocapsid protein antigens from SARS-CoV-2, influenza A and influenza B in direct nasopharyngeal (NP) specimens.
Specimen
Nasopharyngeal
Limit of Detection (LoD)
2019 Novel Coronavirus: 74.8 TCID50/mL
Influenza A
| Influenza Viral Strain |
Calculated |
| A/New Caledonia/20/1999_H1N1 |
8.50×103 |
| A/California/04/2009_H1N1 |
2.11×103 |
| A/PR/8/34_H1N1 |
2.93×103 |
| A/Bean Goose/Hubei/chenhu XVI35-1/2016_H3N2 |
4.94×102 |
| A/Guizhou/54/89_H3N2 |
3.95×102 |
| A/Human/Hubei/3/2005_H3N2 |
2.93×104 |
| A/Bar-headed Goose/QH/BTY2/2015_H5N1 |
1.98×105 |
| A/Anhui/1/2013_H7N9 |
7.90×105 |
Influenza B.
| Influenza Viral Strain |
Calculated |
| B/Victoria |
4.25×103 |
| B/Yamagata |
1.58×102 |
Accuracy
Influenza A
Relative Sensitivity : 86.8%
Relative Specificity: 94%
Accuracy: 92.2%
Influenza B
Relative Sensitivity: 91.7%
Relative Specificity: 97.5%
Accuracy: 96.1%
COVID-19
Relative Sensitivity: 96.6%
Relative Specificity: 100%
Accuracy: 98.9%
Time to results
Read results at 15minutes and no more than 30 minutes.
Kit storage conditions
2~30°C.
Contents
| Test devices | 20 tests |
| Sterilized swabs | 20 pcs |
| Extraction tubes (with 0.5mL extraction | 20 pcs |
| buffer) | 20 pcs |
| Nozzle with filter | 1 pcs |
| Tube Stand | 1 pcs |
Ordering Information
|
Product |
Cat.No. |
Contents |
|
EZERTM Flu & COVID-19 Antigen Duo |
P211137 |
20 Tests |
Product detail pictures:
Related Product Guide:
To create far more benefit for customers is our company philosophy; customer growing is our working chase for New Fashion Design for Rapid Antigen Diagnostic Test - EZER Flu&Covid-19 Antigen Duo rapid test – Genesis , The product will supply to all over the world, such as: Venezuela, Ireland, Nepal, Facing fierce global market competition, we have launched the brand building strategy and updated the spirit of "human-oriented and faithful service", with an aim to gain global recognition and sustainable development.
By Antonio from Cairo - 2018.11.22 12:28
This supplier's raw material quality is stable and reliable, has always been in accordance with the requirements of our company to provide the goods that quality meet our requirements.
By Jodie from Palestine - 2017.12.09 14:01
